Future Match Making: When Pediatric Oncology Meets Organoid Technology
Unlike adult cancers that frequently result from the accumulation in time of mutational “hits” often linked to lifestyle, childhood cancers are emerging as diseases of dysregulated development through massive epigenetic alterations. The ability to reconstruct these differences in cancer models is th...
Main Authors: | Virginie Barbet, Laura Broutier |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.674219/full |
Similar Items
-
Microfluidic Organoids-on-a-Chip: Quantum Leap in Cancer Research
by: Fahriye Duzagac, et al.
Published: (2021-02-01) -
The Organoid Era Permits the Development of New Applications to Study Glioblastoma
by: Francesco Andreatta, et al.
Published: (2020-11-01) -
Patient-Derived Colorectal Cancer Organoids Upregulate Revival Stem Cell Marker Genes following Chemotherapeutic Treatment
by: Rebekah M. Engel, et al.
Published: (2020-01-01) -
Knockout of MMP3 Weakens Solid Tumor Organoids and Cancer Extracellular Vesicles
by: Eman A. Taha, et al.
Published: (2020-05-01) -
Drug screening model meets cancer organoid technology
by: Chen Liu, et al.
Published: (2020-11-01)